Video Experimental Relacionado
Updated: Jan 7, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Eje IGF2BP3-STAT3-METTL3 promueve la progresión maligna en el carcinoma hepatocelular (CHC)
Yang Xu1,2, Yu Cao2, Jingbo Yang1,3
1First Central Hospital of Tianjin Medical University, Tianjin, 300070, China.
La proteína 3 de unión al ARNm del factor de crecimiento similar a la insulina 2 (IGF2BP3) promueve el carcinoma hepatocelular (CHC) al estabilizar el ARNm de IL4R y activar la vía JAK2-STAT3. Esta vía coordina la modificación de N6-metiladenosina (m6A) en la progresión del CHC.
Más Videos Relacionados
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Videos de Conceptos Relacionados
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
TGF - β Signaling Pathway